-
Rousselot® Biomedical launches X-Pure® GelDAT, first ever purified and phenol-functionalized gelatin
GelDAT, combines purity with superior adhesion performance to increase the potential of in-body applications reaching the clinic. Irving, Texas, 20th May 2021 / Sciad Newswire / Rousselot®, a brand of Darling Ingredients, and the global leader of collagen-based solutions1 expands its range of purified, pharmaceutical grade, modified gelatins with the launch of X-Pure® GelDAT – Gelatin Desaminotyrosine. Created in…
-
Antibiotic Research UK announces winners of ‘Bio-Baddie’ competition
York, UK, 18th May 2021 / Sciad Newswire / Antibiotic Research UK (ANTRUK), the world’s first publicly funded charity focused solely on tackling the global threat of drug-resistant infections, is delighted to announce the winners of the 2021 Bio-Baddie art competition. The competition encouraged participants of any age to draw what they think an antibiotic resistant bacteria…
-
Cancer experts call for urgent action on the post-pandemic cancer crisis
Cambridge, UK, 12th May 2021 / Sciad Newswire / Top cancer experts, cancer charities, Royal Colleges and MPs have issued an urgent call for the government to move forward from Covid and start saving lives with cancer funding. In an open letter to the Chancellor Rishi Sunak and Health Secretary Matt Hancock, leading cancer specialist Professor Gordon Wishart, Chief…
-
Stellar line-up confirmed for Bio Integrates 2021
London, UK, 6th May 2021 / Sciad Newswire / Life Science Integrates confirms Dr Andy Richards CBE and Ian McCubbin OBE as keynote speakers for its third Bio Integrates Conference on 20th May 2021. Both keynote speakers have both played pivotal roles over the past year; Andy as an entrepreneur and investor with a track record in founding and scaling…
-
Solentim expands European operations
Bournemouth, UK, 5th May 2021 / Sciad Newswire / Solentim, the trusted global leader in workflows for antibody and cell-based therapies, today announced an expansion of its European operations. The company has established a new EU entity based in Ireland to facilitate frictionless business within the EU. Additionally, Solentim has opened a new warehousing and logistics hub in Germany, to…
-
N-SIDE Production App launched to optimize manufacturing for clinical development and deliver millions in savings
Cambridge, MA, USA and Louvain-la-Neuve, Belgium, 4th May 2021 / Sciad Newswire / N-SIDE, a clinical trial supply optimization expert, launches the N-SIDE Production App. The new app is the latest addition to the N-SIDE Suite and will further enhance end-to-end clinical trial supply chain management by optimizing the manufacturing process. The Production App has already saved a large…
-
Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC
Cleveland, UK, 29th April 2021 / Sciad Newswire / Leading UK peptide and antibody producers, Cambridge Research Biochemicals (CRB) have today signed a new distribution agreement with Fluoroprobes, LLC (FPL) and Click Chemistry Tools (CCT) to add FPL and CCT’s generic fluorescent activated dyes and click chemistry enabled click-reactive dyes to their existing service portfolio. The distribution agreement…
-
Succeeding beyond the blockbuster
Watson-Marlow Fluid Technology Group launches new opinion piece and webinar discussing the manufacturing challenges of personalised medicines. Falmouth, UK, 26th April 2021 / Sciad Newswire / Global leader in fluid management technology, Watson-Marlow Fluid Technology Group (WMFTG), today launches a new article discussing the biopharmaceutical manufacturing challenges of personalised medicines. The opinion piece features insights from bioprocessing experts…
-
Harwell-based Helix Technologies completes funding round led by Midven-managed UK Innovation & Science Seed Fund
Harwell, Oxford, UK, 21st April 2021 / Sciad Newswire / Helix Technologies, developer of resilient, precision antennas for GNSS (Global Navigation Satellite Systems), is pleased to announce it has completed a significant investment round led by the UK Innovation and Science Seed Fund (UKI2S), managed by Midven, supported by Helix’s existing shareholders and incoming private investors. The funding round is…
-
Antibiotic Research UK launches £200,000 small research grants programme to tackle antibiotic resistance
York, UK, 13th April 2021 / Sciad Newswire / Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, launches its 2021 Small Research Grants / Career Development Awards scheme. This is the charity’s largest grants programme to date. The charity will be awarding one grant of up to £50,000 and six grants of up to…